Cargando…

Targeted alpha anticancer therapies: update and future prospects

Targeted alpha therapy (TAT) is an emerging option for local and systemic cancer treatment. Preclinical research and clinical trials show that alpha-emitting radionuclides can kill targeted cancer cells while sparing normal cells, thus reducing toxicity. (223)RaCl(2) (Xofigo(®)) is the first alpha e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allen, Barry J, Huang, Chen-Yu, Clarke, Raymond A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232037/ https://www.ncbi.nlm.nih.gov/pubmed/25422581 http://dx.doi.org/10.2147/BTT.S29947

Ejemplares similares

Microdosimetry for Targeted Alpha Therapy of Cancer
por: Huang, Chen-Yu, et al.
Publicado: (2012)

Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update
por: Khan, Fazlullah, et al.
Publicado: (2016)

Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies
por: Ng, Chau Yee, et al.
Publicado: (2018)

Targeting senescence as an anticancer therapy
por: Bousset, Laura, et al.
Publicado: (2022)

Exploring the Potent Anticancer Activity of Essential Oils and Their Bioactive Compounds: Mechanisms and Prospects for Future Cancer Therapy
por: Mohamed Abdoul-Latif, Fatouma, et al.
Publicado: (2023)

Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil
por: Jardim, José R, et al.
Publicado: (2021)

Targeted Alpha Therapy Approach to the Management of Pancreatic Cancer
por: Allen, Barry J., et al.
Publicado: (2011)

Prediction of individual response to anticancer therapy: historical and future perspectives
por: Unger, Florian T., et al.
Publicado: (2014)

Targeted Radionuclide Therapy: Practical Applications and Future Prospects
por: Zukotynski, Katherine, et al.
Publicado: (2016)

Nanoparticle-based materials in anticancer drug delivery: Current and future prospects
por: Ajith, Saniha, et al.
Publicado: (2023)

An updated overview on the development of new photosensitizers for anticancer photodynamic therapy
por: Zhang, Juan, et al.
Publicado: (2018)

Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
por: Huang, Jau-Ling, et al.
Publicado: (2022)

Apoptosis: A Target for Anticancer Therapy
por: Pfeffer, Claire M., et al.
Publicado: (2018)

Lysosomes as a Target of Anticancer Therapy
por: Trybus, Wojciech, et al.
Publicado: (2023)

Pentacyclic Triterpenoid Phytochemicals with Anticancer Activity: Updated Studies on Mechanisms and Targeted Delivery
por: Nistor, Madalina, et al.
Publicado: (2023)

Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future
por: Pouliquen, Daniel L., et al.
Publicado: (2023)

Advances in Targeting HER3 as an Anticancer Therapy
por: Jiang, Ning, et al.
Publicado: (2012)

Nanoparticles in Targeted Alpha Therapy
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2020)

Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
por: Anwar, Sirajudheen, et al.
Publicado: (2022)

Molecular targeted therapy for anticancer treatment
por: Min, Hye-Young, et al.
Publicado: (2022)

Systemic use of tumor necrosis factor alpha as an anticancer agent
por: Roberts, Nicholas J., et al.
Publicado: (2011)

Targeting necroptosis in anticancer therapy: mechanisms and modulators
por: Wu, Ying, et al.
Publicado: (2020)

Glucose Transporters as a Target for Anticancer Therapy
por: Pliszka, Monika, et al.
Publicado: (2021)

Targeting CDK4/6 for Anticancer Therapy
por: Qi, Jiating, et al.
Publicado: (2022)

Role of endoscopic ultrasound in anticancer therapy: Current evidence and future perspectives
por: Bratanic, Andre, et al.
Publicado: (2021)

Macrophage-Based Microrobots for Anticancer Therapy: Recent Progress and Future Perspectives
por: Nguyen, Van Du, et al.
Publicado: (2023)

Targeting heart failure with preserved ejection fraction: current status and future prospects
por: Kanwar, Manreet, et al.
Publicado: (2016)

Three-Dimensional In Vitro Tumor Spheroid Models for Evaluation of Anticancer Therapy: Recent Updates
por: Nayak, Pallavi, et al.
Publicado: (2023)

In Vitro and In Vivo Anticancer Activity of Basil (Ocimum spp.): Current Insights and Future Prospects
por: Perna, Simone, et al.
Publicado: (2022)

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
por: Pascual-Camps, Isabel, et al.
Publicado: (2014)

Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy
por: Huang, Tzu-Ting, et al.
Publicado: (2017)

Sulforaphane’s Multifaceted Potential: From Neuroprotection to Anticancer Action
por: Otoo, Raymond A., et al.
Publicado: (2023)

Imidazoles as Potential Anticancer Agents: An Update on Recent Studies
por: Sharma, Pankaj, et al.
Publicado: (2021)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018)

Past, Present, and Future of Anticancer Nanomedicine
por: Kim, Kyungeun, et al.
Publicado: (2020)

Current applications and future prospects of nanomaterials in tumor therapy
por: Huang, Yu, et al.
Publicado: (2017)

Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy
por: Desideri, Enrico, et al.
Publicado: (2019)

Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy
por: Yang, Seong-Bin, et al.
Publicado: (2022)

The Potential of Senescence as a Target for Developing Anticancer Therapy
por: Jo, Hyein, et al.
Publicado: (2023)

Plasma-Conditioned Liquids as Anticancer Therapies In Vivo: Current State and Future Directions
por: Solé-Martí, Xavi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pffie39a4kcif7hh4qhi154ds8